Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458507077943v1
13/8/1004    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glanz, B.
Right arrow Articles by Weiner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glanz, B.
Right arrow Articles by Weiner, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
This version was published on September 1, 2007
Multiple Sclerosis, Vol. 13, No. 8, 1004-1010 (2007)
DOI: 10.1177/1352458507077943

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis

BI Glanz

Department of Neurology, Brigam and Women's Hospital, Harvard Medical School, Boston, MA, USA, bglanz{at}partners.org

CM Holland

Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

SA Gauthier

Department of Neurology, Brigam and Women's Hospital, Harvard Medical School, Boston, MA, USA

EL Amunwa

Department of Neurology, Brigam and Women's Hospital, Harvard Medical School, Boston, MA, USA

Z. Liptak

Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

MK Houtchens

Department of Neurology, Brigam and Women's Hospital, Harvard Medical School, Boston, MA, USA

RA Sperling

Department of Neurology, Brigam and Women's Hospital, Harvard Medical School, Boston, MA, USA

SJ Khoury

Department of Neurology, Brigam and Women's Hospital, Harvard Medical School, Boston, MA, USA

CRG Guttmann

Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

HL Weiner

Department of Neurology, Brigam and Women's Hospital, Harvard Medical School, Boston, MA, USA

Cognitive dysfunction is common in patients with multiple sclerosis (MS), and has been associated with MRI measures of lesion burden and atrophy. Little is known about the prevalence of cognitive impairment in patients with early MS. The associations between cognitive impairment and MRI measures of disease severity early in the disease course are also unclear. This study used a brief battery of cognitive tests to determine the prevalence and pattern of cognitive impairment in patients with clinically isolated syndromes or newly diagnosed MS. The associations between cognitive impairment and MRI measures of disease severity early in the disease course were also examined. Ninety-two patients with clinically isolated syndromes or the diagnosis of MS within the last 3 years participating in the CLIMB study underwent a neurologic examination, neuropsychological evaluation and MRI at 1.5T. Forty-nine percent of patients were impaired on one or more cognitive measures. There were no significant correlations between cognitive scores and MRI measures of disease severity including total T2 lesion volume, normal appearing white matter volume, grey matter volume, and brain parenchymal fraction. These findings suggest that cognitive impairment may predate the appearance of gross structural abnormalities on MRI and serve as an early marker of disease activity in MS. Multiple Sclerosis 2007; 13: 1004—1010. http://msj.sagepub.com

Key Words: clinically isolated syndrome • cognition disorder • magnetic resonance imaging • multiple sclerosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
P Nilsson, I Rorsman, E. Larsson, B Norrving, and M Sandberg-Wollheim
Cognitive dysfunction 24-31 years after isolated optic neuritis
Multiple Sclerosis, August 1, 2008; 14(7): 913 - 918.
[Abstract] [PDF]


Home page
Mult SclerHome page
B Duque, J Sepulcre, B Bejarano, L Samaranch, P Pastor, and P Villoslada
Memory decline evolves independently of disease activity in MS
Multiple Sclerosis, August 1, 2008; 14(7): 947 - 953.
[Abstract] [PDF]